Norris Medicines Limited (BOM:524414)

Norris Medicines Statistics

Total Valuation

BOM:524414 has a market cap or net worth of INR 136.31 million. The enterprise value is 350.38 million.

Market Cap	136.31M
Enterprise Value	350.38M

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:524414 has 10.00 million shares outstanding. The number of shares has decreased by -0.13% in one year.

Current Share Class	10.00M
Shares Outstanding	10.00M
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	-0.38%
Owned by Insiders (%)	24.00%
Owned by Institutions (%)	1.50%
Float	2.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.87
PB Ratio	-0.86
P/TBV Ratio	n/a
P/FCF Ratio	19.17
P/OCF Ratio	18.85
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-22.77
EV / Sales	4.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	49.26

Financial Position

The company has a current ratio of 0.57

Current Ratio	0.57
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	30.19
Interest Coverage	-2.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-4.82%
Return on Invested Capital (ROIC)	-16.76%
Return on Capital Employed (ROCE)	-40.16%
Weighted Average Cost of Capital (WACC)	0.86%
Revenue Per Employee	2.21M
Profits Per Employee	-466,300
Employee Count	33
Asset Turnover	0.55
Inventory Turnover	1.11

Taxes

In the past 12 months, BOM:524414 has paid 594,256 in taxes.

Income Tax	594,256
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.95% in the last 52 weeks. The beta is -0.87, so BOM:524414's price volatility has been lower than the market average.

Beta (5Y)	-0.87
52-Week Price Change	-44.95%
50-Day Moving Average	15.58
200-Day Moving Average	16.82
Relative Strength Index (RSI)	40.52
Average Volume (20 Days)	800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524414 had revenue of INR 72.84 million and -15.39 million in losses. Loss per share was -1.55.

Revenue	72.84M
Gross Profit	24.32M
Operating Income	-10.21M
Pretax Income	-14.79M
Net Income	-15.39M
EBITDA	-5.04M
EBIT	-10.21M
Loss Per Share	-1.55

Balance Sheet

The company has 646,000 in cash and 214.72 million in debt, with a net cash position of -214.07 million or -21.41 per share.

Cash & Cash Equivalents	646,000
Total Debt	214.72M
Net Cash	-214.07M
Net Cash Per Share	-21.41
Equity (Book Value)	-158.96M
Book Value Per Share	-15.94
Working Capital	-46.93M

Cash Flow

In the last 12 months, operating cash flow was 7.23 million and capital expenditures -117,394, giving a free cash flow of 7.11 million.

Operating Cash Flow	7.23M
Capital Expenditures	-117,394
Free Cash Flow	7.11M
FCF Per Share	0.71

Margins

Gross margin is 33.39%, with operating and profit margins of -14.02% and -21.13%.

Gross Margin	33.39%
Operating Margin	-14.02%
Pretax Margin	-20.31%
Profit Margin	-21.13%
EBITDA Margin	-6.91%
EBIT Margin	-14.02%
FCF Margin	9.76%

Dividends & Yields

BOM:524414 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.13%
Shareholder Yield	0.13%
Earnings Yield	-11.29%
FCF Yield	5.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 22, 2013. It was a reverse split with a ratio of 0.3000003.

Last Split Date	Aug 22, 2013
Split Type	Reverse
Split Ratio	0.3000003

Scores

BOM:524414 has an Altman Z-Score of -2.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.43
Piotroski F-Score	4